OTC · Consumer staples

Tanke Biosciences Corp (TNBI)

Tanke Biosciences Corp brought in $23M of revenue over the twelve months to September 30, 2013, down 19.5% from a year earlier. It posted a net loss of $1.6M. In fiscal 2012 capital spending exceeded operating cash flow by $2M. At September 30, 2013 it held $5.1M in cash against $1.9M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 14, 2013.

Watch TNBI in 60 seconds

Price

$0.01

0.00% on the day · September 25, 2026

52-week range $0.01 to $0.06

Market cap

$133.2K

Revenue (last 12 months)

$23M

-19.5% year on year

Net margin

-7.1%

What Tanke Biosciences Corp does

Tanke Biosciences Corp is registered with the SEC under industry code SIC 2040 (Grain Mill Products). Its shares trade on OTC under the ticker TNBI.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2012	$28.6M	$4.5M	-$210.2K	-$0.02	-$2M
2011	$23.8M	$1.7M	-$3.1M	-$0.24	$3M
2011	$20.1M	$4.4M	$2.7M	$0.34	$4.3M
2009	n/a	n/a	$2.6M	n/a	n/a

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Tanke Biosciences Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

March 19, 2024
Form RW filing RW
March 15, 2024
Form RW filing RW
February 8, 2024
Form 10-12G filing 10-12G
December 31, 2013
Deregistration 15-12G
December 26, 2013
Auditor change 8-K
November 22, 2013
Debt repayment accelerated 8-K
November 14, 2013
Quarterly report 10-Q · period to September 30, 2013Revenue fell 39% to $6M versus the same quarter last year; diluted EPS -$0.02 versus $0.07.
October 4, 2013
Executive or director change 8-K
August 29, 2013
Material agreement 8-K
August 14, 2013
Quarterly report 10-Q · period to June 30, 2013Revenue fell 25% to $5.6M versus the same quarter last year; diluted EPS $0.01 versus $0.02.

Recent insider filings (Forms 3, 4 and 144): 6, the latest on February 24, 2011. Insider transactions on SEC

All filings on SEC EDGAR

Questions about TNBI

What does Tanke Biosciences Corp do?

Tanke Biosciences Corp is registered with the SEC under industry code SIC 2040 (Grain Mill Products). Its shares trade on OTC under the ticker TNBI.

Is Tanke Biosciences Corp profitable?

No. Over the twelve months to September 30, 2013 it reported a net loss of $1.6M on revenue of $23M.

How much revenue does Tanke Biosciences Corp make?

Over the twelve months to September 30, 2013 Tanke Biosciences Corp reported revenue of $23M. That is 19.5% less than a year earlier.

When did Tanke Biosciences Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 14, 2013. It covers the period to September 30, 2013. Its newest filing of any kind is the form RW filing from March 19, 2024.

Similar companies

Compare TNBI with

Compare TNBI with any company

Follow TNBI

Get an email when Tanke Biosciences Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow TNBI: get an email when it files

Where the numbers come from

Financial figures are the values Tanke Biosciences Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.